- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stereotactic body radiotherapy for organ-confined prostate cancer ; volume:10 ; number:1 ; day:1 ; month:2 ; year:2010 ; pages:1-10 ; date:12.2010
BMC urology ; 10, Heft 1 (1.2.2010), 1-10, 12.2010
- Urheber
-
Katz, Alan J.
- Beteiligte Personen und Organisationen
-
Santoro, Michael
Ashley, Richard
Diblasio, Ferdinand
Witten, Matthew
SpringerLink (Online service)
- DOI
-
10.1186/1471-2490-10-1
- URN
-
urn:nbn:de:1111-2016071624184
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 09:01 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Katz, Alan J.
- Santoro, Michael
- Ashley, Richard
- Diblasio, Ferdinand
- Witten, Matthew
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
Safety of high-dose-rate stereotactic body radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
Safety of high-dose-rate stereotactic body radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study
Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
Safety of high-dose-rate stereotactic body radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis